Merck Clarifies ClinicalTrials.gov Postings; Listed As Sponsor Of 13 Studies

Merck is enrolling patients in three type 2 diabetes trials - including pioglitazone and metformin add-on studies - for a late-stage investigational drug, according to the company's recently updated postings on the HHS-sponsored website ClinicalTrials.gov